Bayer Aktiengesellschaft (ETR: BAYN)
Germany
· Delayed Price · Currency is EUR
19.72
+0.73 (3.84%)
Jan 6, 2025, 5:44 PM CET
Bayer Aktiengesellschaft Revenue
Bayer Aktiengesellschaft had revenue of 9.97B EUR in the quarter ending September 30, 2024, a decrease of -3.62%. This brings the company's revenue in the last twelve months to 46.74B, down -2.17% year-over-year. In the year 2023, Bayer Aktiengesellschaft had annual revenue of 47.64B, down -6.11%.
Revenue (ttm)
46.74B
Revenue Growth
-2.17%
P/S Ratio
0.41
Revenue / Employee
495.93K
Employees
96,931
Market Cap
19.37B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 47.64B | -3.10B | -6.11% |
Dec 31, 2022 | 50.74B | 6.66B | 15.10% |
Dec 31, 2021 | 44.08B | 2.68B | 6.48% |
Dec 31, 2020 | 41.40B | -2.15B | -4.93% |
Dec 31, 2019 | 43.55B | 6.80B | 18.52% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 20.96B |
Siemens Healthineers AG | 22.36B |
Fresenius SE & Co. KGaA | 22.81B |
Sartorius Aktiengesellschaft | 3.32B |
Fresenius Medical Care AG | 19.24B |
Carl Zeiss Meditec AG | 2.07B |
SCHOTT Pharma AG & Co. KGaA | 957.09M |
Fielmann Group AG | 2.16B |
Bayer Aktiengesellschaft News
- 3 days ago - Bayer wins last pending Roundup case in Australia - Seeking Alpha
- 3 days ago - Bayer Secures End of Roundup Weedkiller Litigation in Australia - The Wall Street Journal
- 3 days ago - Bayer Secures End of Roundup Weedkiller Litigation in Australia - WSJ
- 3 days ago - Bayer: Federal Court Brings an End to Roundup™ Litigation in Australia - Business Wire
- 3 days ago - Bayer: Sell And Be Done With It - Seeking Alpha
- 13 days ago - A year after Bayer got rid of bosses and asked staff to self-organize, its CEO says attrition has fallen - Fortune
- 14 days ago - Bayer's CEO said budgets represent the worst of corporate bureaucracy. He decided to turn the process on its head. - Business Insider
- 20 days ago - Bayer Eye Drug Shows Positive Results in Late-Stage Trial - The Wall Street Journal